This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Duarte, Los Angeles +3 more locations
Sponsor: ABL Bio, Inc.
Sex: All·Age: 18+
Code: NCT04762641·Phase 1·Recruiting·Listed Feb 2021